Annual Conference

2024 NCCN Annual Conference Call for Abstracts

The 2024 NCCN Annual Conference was held Friday, April 5 – Sunday, April 7, 2024 at the Orlando World Center Marriott and virtually.

View Press Coverage

Save the Dates

NCCN 2025 Nursing Program: Advancing Oncology Nursing™
Thursday, March 27, 2025
New location! Caribe Royale Orlando, Orlando, FL

NCCN 2025 Annual Conference
Friday, March 28 – Sunday, March 30, 2025  
New location! Caribe Royale Orlando, Orlando, FL 

NCCN 2026 Annual Conference
Friday, March 27 – Sunday, March 29, 2026 
Caribe Royale Orlando, Orlando, FL 


Continuing Education

NCCN Annual Conference 2024 Higlights

Conference attendees will have the opportunity to view conference sessions on-demand in the Virtual Event Platform through June 2024. Recorded presentations will be available on the NCCN Continuing Educational Portal,, in late June 2024.

Experts from leading cancer centers came together to discuss updates to NCCN Guidelines®, the latest advances across several cancer types, and emerging issues in oncology.

CE credit was available for the oncology team. There were 35 live and on-demand educational sessions!


Clinical Updates in Oncology Across the Following Topics:

  • Acute Myeloid Leukemia
  • Bladder Cancer
  • Breast Cancer
  • Breast Cancer Screening
  • Endometrial Cancer
  • Gastrointestinal Cancers
  • Genetics/Familial High-Risk Assessment
  • Head and Neck Cancers
  • Kidney Cancer
  • Melanoma: Cutaneous
  • Multiple Myeloma
  • Neuroblastoma
  • Non-Small Cell Lung Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Rectal Cancer
  • Skin Cancers
  • Small Cell Lung Cancer
  • Cancer-Related Fatigue
  • Distress Management
  • Survivorship      

Best Practices:

  • Artificial Intelligence in Oncology
  • Balancing Inpatient and Outpatient Oncology Care
  • Best Practices in Care Team Communication Technology
  • Capturing Structured Data in the Electronic Health Record
  • Collection and Utilization of Sex/Sex Characteristics, Sexual Orientation, and Gender Identity (SSOGI) Data
  • High-Risk Prevention Programs: Identifying Services for High-Risk Patients
  • Improving Infusion Efficiency to Optimize Oncology Care
  • Changing Economics in Cancer Care: Optimizing Resources and Strategic Tactics to Improve Patient Outcomes and Protect the Workforce
  • Successful Team Care Models: Allocation of Responsibilities and Team Metrics
  • The Evolving Role of Advanced Practice Providers in Oncology Care

This activity is supported by educational grants from:

  • AstraZeneca
  • Coherus BioSciences
  • Dendreon Pharmaceuticals LLC.
  • Eisai
  • Exact Sciences
  • Genentech, a member of the Roche Group
  • GSK
  • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
  • Lilly
  • Menarini-Stemline
  • Novartis
  • Novocure
  • Olympus Corporation of the Americas
  • Sanofi
  • Sirtex
  • Taiho Oncology, Inc.

Supported by a grant from:

  • Pfizer Inc.

This project has been made possible in part by a grant from:

  • Varian Medical Systems, a Siemens Healthineers company /Global Medical Education Grant Program

Supported by independent educational grants from:

  • Daiichi Sankyo
  • Incyte Corporation
  • Merck & Co., Inc., Rahway, NJ, USA

Supported by independent medical education grants from:

  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Regeneron Pharmaceuticals, Inc.

Supported by a medical education grant from:

  • Karyopharm Therapeutics

Exhibit Hall

Conference attendees can view virtual exhibits in the Virtual Event Platform through June 2024.

View Exhibit Guide

For exhibitor opportunities, contact Jennifer Tredwell, Vice President, NCCN Marketing and Communications.

Patient Advocacy Pavilion Sponsors


Incyte Corporation
Johnson & Johnson